Patents by Inventor Ping Ling

Ping Ling has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080102476
    Abstract: Assay methods for analyzing whole blood to detect histamine H4 receptor-mediated effects, such as eosinophil shape change, cytoskeletal change, adhesion molecule up-regulation, or calcium flux are described. Such methods are useful in clinical and diagnostic applications.
    Type: Application
    Filed: September 24, 2004
    Publication date: May 1, 2008
    Inventors: Lars Karlsson, Wai-Ping Leung, Ping Ling, Robin Thurmond
  • Publication number: 20060045348
    Abstract: An automated system that conducts, monitors, and validates a cell-line-based biological experiment including one or more treatment compounds or other external stimuli. In one preferred embodiment, the system comprises two principal subsystems, and optionally accessory subsystems. A first principal subsystem is an automated laboratory experiment manager for designing the biological experiment, for constructing an assay plate used to conduct the biological experiment, and for managing one or more of the processes that constitute the biological experiment. A second principal subsystem is an automated data analysis manager for analyzing images, for instance produced by the image production system, to detect image data including biological markers and objects, for analyzing the resulting image data to produce biological data, and for analyzing the biological data to produce biological phenotypes and treatment compound signatures.
    Type: Application
    Filed: October 19, 2005
    Publication date: March 2, 2006
    Inventors: Eskinder Kiros, Ping Ling, Robert Muller, Ramesh Venkat, Wesley Zink
  • Patent number: 6999607
    Abstract: An automated system that conducts, monitors, and validates a cell-line-based biological experiment including one or more treatment compounds or other external stimuli. In one preferred embodiment, the system comprises two principal subsystems, and optionally accessory subsystems. A first principal subsystem is an automated laboratory experiment manager for designing the biological experiment, for constructing an assay plate used to conduct the biological experiment, and for managing one or more of the processes that constitute the biological experiment. A second principal subsystem is an automated data analysis manager for analyzing images, for instance produced by the image production system, to detect image data including biological markers and objects, for analyzing the resulting image data to produce biological data, and for analyzing the biological data to produce biological phenotypes and treatment compound signatures.
    Type: Grant
    Filed: February 20, 2002
    Date of Patent: February 14, 2006
    Assignee: Cytokinetics, Inc.
    Inventors: Eskinder Kiros, Ping Ling, Robert J. Muller, Ramesh Venkat, Wesley A. Zink
  • Publication number: 20050083121
    Abstract: The invention disclosed a trace following powered amplifier mainly used in solving the problem of circuit overheating caused by long test time, especially to an amplifier applicable to a low frequency and low distortion test apparatus such as a capacitor ripple current tester. The amplifier of present invention can make the most efficient use of electrical energy by incorporating a low frequency voltage peak value of an amplifier signal plus an estimated tolerance.
    Type: Application
    Filed: March 30, 2004
    Publication date: April 21, 2005
    Inventors: Ming Tsai, Ping Ling
  • Publication number: 20040127395
    Abstract: Methods are disclosed for identifying histamine receptor modulators that affect mast cell or basophil chemotaxis, and the use of such histamine H4 receptor modulators for the prevention, treatment, induction, or other desired modulation of asthma and/or allergic responses, or diseases and/or conditions that are modulated, affected or caused by asthma or allergic responses. Also disclosed is the use of histamine H4 receptor modulators for the prevention, treatment, induction, or other desired modulation of mast cell or basophil chemotactic responses, such as migration to a particular site, or diseases and/or conditions that are modulated, affected or caused by mast cell or basophil chemotaxis.
    Type: Application
    Filed: September 5, 2003
    Publication date: July 1, 2004
    Inventors: Pragnya J. Desai, Paul J. Dunford, Claudia L. Hofstra, Lars G. Karlsson, Wai-Ping Leung, Ping Ling, Robin L. Thurmond
  • Publication number: 20040117124
    Abstract: An automated system that conducts, monitors, and validates a cell-line-based biological experiment including one or more treatment compounds or other external stimuli. In one preferred embodiment, the system comprises two principal subsystems, and optionally accessory subsystems. A first principal subsystem is an automated laboratory experiment manager for designing the biological experiment, for constructing an assay plate used to conduct the biological experiment, and for managing one or more of the processes that constitute the biological experiment. A second principal subsystem is an automated data analysis manager for analyzing images, for instance produced by the image production system, to detect image data including biological markers and objects, for analyzing the resulting image data to produce biological data, and for analyzing the biological data to produce biological phenotypes and treatment compound signatures.
    Type: Application
    Filed: January 12, 2004
    Publication date: June 17, 2004
    Inventors: Eskinder Kiros, Ping Ling, Robert J Muller, Ramesh Venkat, Wesley A Zink
  • Patent number: 5662969
    Abstract: A coating apparatus and method for applying a coating to a workpiece, comprising:a vessel to contain molten metal;an induction coil disposed about said vessel; and,temperature regulation means;wherein, in use, said induction coil induces a magnetic field within said vessel such that a meniscus of molten metal is formed above said vessel, through which said workpiece is passed for coating, whilst said temperature regulation means regulates temperature of said molten metal and/or controls the meniscus height of said meniscus.
    Type: Grant
    Filed: July 26, 1996
    Date of Patent: September 2, 1997
    Assignee: Graham Group
    Inventor: Ping Ling
  • Patent number: 5650492
    Abstract: Analysis of the culture media of p40-transfected COS cells indicated the presence of 40 kDa monomers and 80 kDa disulfide-linked homodimers. Examination of partially purified p40 recombinant proteins demonstrated that only the homodimer but not the monomer binds to the IL-12 receptor. Partially purified 80 kDa homodimer inhibited [.sup.125 I]IL-12 binding to PHA-activated human lymphoblasts with an IC.sub.50 of 80 ng/ml, which is similar to the IC.sub.50 value (20 ng/ml) for the human IL-12 heterodimer. Although neither the 40 kDa monomer nor the 80 kDa dimer could stimulate human PHA-blast proliferation, the 80 kDa dimer inhibited IL-12-induced proliferation in a dose-dependent manner with an IC.sub.50 of 1 .mu.g/ml. The IL-12 p40 subunit contains the essential epitopes for receptor binding, but they are only active when p40 is covalently associated with a second protein such as p35 or p40. When p40 is associated with the p35 subunit, the heterodimer acts as an agonist mediating biologic activity.
    Type: Grant
    Filed: April 18, 1995
    Date of Patent: July 22, 1997
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Maurice Kent Gately, John Hakimi, Ping Ling